| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.37 | 5e-18 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-14 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.39 | 2e-08 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |